The North America Sterility Testing Market should witness market growth of 9.7% CAGR during the forecast period (2023-2029).
Sterility testing is performed at all stages of producing pharmaceutical and biological goods to reduce the possibility of product contamination. The frequency of sterility testing in the industries is rising along with the demand for medical devices and pharmaceuticals for various health issues, which is anticipated to drive the market. Large investments in the market are thought to be a result of sterility testing & its related services gaining popularity over time.
In addition, the strict regulations defined by regulatory bodies such as FDA, have led to expansion of sterility testing market. Significant factors driving the growth of the sterility testing market include the expansion of the biotechnology & pharmaceutical sector and the rise in research & development initiatives in the life sciences industry.
Increased government initiatives in the biotechnology field and rising sterilized product demand, particularly in the healthcare industry, contribute to the market's overall expansion. Additional factors that speed up the market's overall expansion and contribute to its success over the projected period include government funding, rising healthcare expenditures, and the increasing usage of technologically advanced equipment in healthcare organizations.
The presence of numerous international pharmaceutical & biopharmaceutical businesses as well as significant financing for research & development by the government as well as private organizations in the United States are credited with the country's substantial market share in the sterility testing market. Furthermore, the market is expanding because of the increased incidence of diabetes and the Canadian government's increasing funding of research & development related to the disease.
The US market dominated the North America Sterility Testing Market by Country in 2022; thereby, achieving a market value of $598.8 million by 2029. The Canada market is experiencing a CAGR of 12.2% during (2023-2029). Additionally, The Mexico market would exhibit a CAGR of 11.3% during (2023-2029).
Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Test Type, the market is segmented into Membrane Filtration, Direct Inoculation and Others. Based on Application, the market is segmented into Pharmaceuticals & Biologicals, Medical Devices and Others. Based on End-user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., SGS S.A., Merck KGaA, BioMérieux S.A., WuXi AppTec Co., Ltd., Sartorius AG, Samsung Biologics Co., Ltd. (Samsung Group), Nelson Laboratories, LLC (Sotera Health Company) and Pacific Biolabs, Inc.
Sterility testing is performed at all stages of producing pharmaceutical and biological goods to reduce the possibility of product contamination. The frequency of sterility testing in the industries is rising along with the demand for medical devices and pharmaceuticals for various health issues, which is anticipated to drive the market. Large investments in the market are thought to be a result of sterility testing & its related services gaining popularity over time.
In addition, the strict regulations defined by regulatory bodies such as FDA, have led to expansion of sterility testing market. Significant factors driving the growth of the sterility testing market include the expansion of the biotechnology & pharmaceutical sector and the rise in research & development initiatives in the life sciences industry.
Increased government initiatives in the biotechnology field and rising sterilized product demand, particularly in the healthcare industry, contribute to the market's overall expansion. Additional factors that speed up the market's overall expansion and contribute to its success over the projected period include government funding, rising healthcare expenditures, and the increasing usage of technologically advanced equipment in healthcare organizations.
The presence of numerous international pharmaceutical & biopharmaceutical businesses as well as significant financing for research & development by the government as well as private organizations in the United States are credited with the country's substantial market share in the sterility testing market. Furthermore, the market is expanding because of the increased incidence of diabetes and the Canadian government's increasing funding of research & development related to the disease.
The US market dominated the North America Sterility Testing Market by Country in 2022; thereby, achieving a market value of $598.8 million by 2029. The Canada market is experiencing a CAGR of 12.2% during (2023-2029). Additionally, The Mexico market would exhibit a CAGR of 11.3% during (2023-2029).
Based on Product, the market is segmented into Kits & Reagents, Instruments and Services. Based on Test Type, the market is segmented into Membrane Filtration, Direct Inoculation and Others. Based on Application, the market is segmented into Pharmaceuticals & Biologicals, Medical Devices and Others. Based on End-user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Charles River Laboratories International, Inc., SGS S.A., Merck KGaA, BioMérieux S.A., WuXi AppTec Co., Ltd., Sartorius AG, Samsung Biologics Co., Ltd. (Samsung Group), Nelson Laboratories, LLC (Sotera Health Company) and Pacific Biolabs, Inc.
Scope of the Study
By Product
- Kits & Reagents
- Instruments
- Services
By Test Type
- Membrane Filtration
- Direct Inoculation
- Others
By Application
- Pharmaceuticals & Biologicals
- Medical Devices
- Others
By End-user
- Pharmaceutical Companies
- Biotechnology Companies
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Charles River Laboratories International, Inc.
- SGS S.A.
- Merck KGaA
- BioMérieux S.A.
- WuXi AppTec Co., Ltd.
- Sartorius AG
- Samsung Biologics Co., Ltd. (Samsung Group)
- Nelson Laboratories, LLC (Sotera Health Company)
- Pacific Biolabs, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Sterility Testing Market by Product
Chapter 4. North America Sterility Testing Market by Test Type
Chapter 5. North America Sterility Testing Market by Application
Chapter 6. North America Sterility Testing Market by End User
Chapter 7. North America Sterility Testing Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Charles River Laboratories International, Inc.
- SGS S.A.
- Merck KGaA
- BioMérieux S.A.
- WuXi AppTec Co., Ltd.
- Sartorius AG
- Samsung Biologics Co., Ltd. (Samsung Group)
- Nelson Laboratories, LLC (Sotera Health Company)
- Pacific Biolabs, Inc.
Methodology
LOADING...
